LUPKYNIS

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Italy, Lithuania, Romania, Spain, UK.

Active ingredients

The drug LUPKYNIS contains one active pharmaceutical ingredient (API):

1	Voclosporin UNII 2PN063X6B1 - VOCLOSPORIN
	Voclosporin is a calcineurin-inhibitor immunosuppressant that inhibits calcineurin in a dose-dependent manner. The immunosuppressant activity results in inhibition of lymphocyte proliferation, T-cell cytokine production, and expression of T-cell activation surface antigens.
	Read more about Voclosporin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LUPKYNIS Soft capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AD03		L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AD Calcineurin inhibitors
Discover more medicines within L04AD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	3040681, 3041165
ES	Centro de información online de medicamentos de la AEMPS	1221678001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	114883
FR	Base de données publique des médicaments	63205919
IT	Agenzia del Farmaco	050355015
LT	Valstybinė vaistų kontrolės tarnyba	1095544, 1096438
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W69557001, W69557002
US	FDA, National Drug Code	75626-001